The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies.
pancreatic cancer
pancreatic cancer novel therapy
pancreatic cancer treatment
pancreatic ductal adenocarcinoma
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
06 Apr 2021
06 Apr 2021
Historique:
received:
01
03
2021
revised:
25
03
2021
accepted:
27
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the US, and it is expected to be the second leading cause of cancer deaths by 2030. The lack of effective early screening tests and alarming symptoms with early undetectable micro-metastasis at the time of presentation play a vital role in the high death rate from pancreatic cancer. In addition to this, the low mutation burden in pancreatic cancer, low immunological profile, dense tumorigenesis stroma, and decreased tumor sensitivity to cytotoxic drugs contribute to the low survival rates in PDAC patients. Despite breakthroughs in chemotherapeutic and immunotherapeutic drugs, pancreatic cancer remains one of the solid tumors that exhibit meager curative rates. Therefore, researchers must dedicate more effort to understanding the pathology and immunological behavior of PDAC, in addition to properly utilizing more advanced screening modalities and new therapeutic agents. In our review, we focus mainly on the latest updates from clinical guidelines and novel therapies that have been recently investigated or are under investigation for PDAC. We used PubMed as a search tool for finding original research articles addressing the latest developments in diagnosing and treating PDAC. Additionally, we also used the clinical trials published on clinicaltrialsgov as sources for our data.
Identifiants
pubmed: 33917380
pii: biomedicines9040389
doi: 10.3390/biomedicines9040389
pmc: PMC8067364
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
Eur J Cancer. 2019 Feb;108:78-87
pubmed: 30654298
Ther Adv Med Oncol. 2012 Nov;4(6):341-6
pubmed: 23118809
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Clin Cancer Res. 2019 Sep 15;25(18):5493-5502
pubmed: 31126960
Cancer Cell. 2011 Jun 14;19(6):715-27
pubmed: 21665146
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Cancer Discov. 2017 Apr;7(4):400-409
pubmed: 28183697
Science. 2011 Mar 25;331(6024):1612-6
pubmed: 21436454
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Chin Clin Oncol. 2017 Dec;6(6):59
pubmed: 29307199
Eur J Cancer. 2012 Jul;48(10):1434-42
pubmed: 22119354
Nat Rev Clin Oncol. 2020 Feb;17(2):108-123
pubmed: 31705130
EBioMedicine. 2020 Mar;53:102675
pubmed: 32113160
Pathol Int. 2014 Jan;64(1):10-9
pubmed: 24471965
Cancer Res. 2000 Jul 15;60(14):3717-21
pubmed: 10919639
Surgery. 2014 Aug;156(2):280-9
pubmed: 24851723
J Clin Oncol. 2001 Jan 1;19(1):145-56
pubmed: 11134207
Lancet Oncol. 2020 Mar;21(3):e135-e145
pubmed: 32135117
J Exp Clin Cancer Res. 2018 Jul 9;37(1):140
pubmed: 29986755
J Clin Oncol. 2016 Nov 10;34(32):3914-3920
pubmed: 27621395
Science. 2009 Jun 12;324(5933):1457-61
pubmed: 19460966
Cancer Biol Ther. 2018 Apr 3;19(4):316-327
pubmed: 29303405
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Am Soc Clin Oncol Educ Book. 2018 May 23;38:300-305
pubmed: 30231408
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Cell. 2018 Jan 25;172(3):578-589.e17
pubmed: 29373830
ESMO Open. 2020;5(1):e000578
pubmed: 33551067
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Int J Oncol. 2006 Feb;28(2):479-86
pubmed: 16391804
Ann Oncol. 2017 Oct 1;28(10):2429-2435
pubmed: 28961832
Clin Cancer Res. 2012 Apr 15;18(8):2316-25
pubmed: 22261800
Pancreatology. 2018 Jan;18(1):2-11
pubmed: 29191513
Front Oncol. 2020 Feb 28;10:245
pubmed: 32185128
J Clin Oncol. 2007 May 20;25(15):1960-6
pubmed: 17452677
Therap Adv Gastroenterol. 2019 Sep 25;12:1756284819878660
pubmed: 31598136
Pol Przegl Chir. 2018 Apr 30;90(2):45-53
pubmed: 29773761
Future Oncol. 2018 Jan;14(1):13-22
pubmed: 29235360
Gastroenterology. 2018 Jul;155(1):29-32
pubmed: 29567081
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
Ann Oncol. 2001 Apr;12(4):519-24
pubmed: 11398887
Cancer Discov. 2016 Mar;6(3):270-85
pubmed: 26715645
JAMA Oncol. 2017 Apr 1;3(4):516-522
pubmed: 27978579
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):153-168
pubmed: 32005945
Gut. 2017 Jan;66(1):124-136
pubmed: 27402485
Trends Biochem Sci. 2014 Feb;39(2):91-100
pubmed: 24388967
Oncology. 2019;97(2):102-111
pubmed: 31230047
BMC Cancer. 2014 Jun 07;14:411
pubmed: 24906700
Clin Transl Gastroenterol. 2013 Mar 21;4:e33
pubmed: 23515131
J Clin Oncol. 2020 Jun 1;38(16):1763-1773
pubmed: 32105518
Int J Med Sci. 2020 Feb 4;17(4):422-427
pubmed: 32174772
Clin Cancer Res. 2017 Apr 1;23(7):1638-1646
pubmed: 28373362
Br J Cancer. 2014 Aug 26;111(5):817-22
pubmed: 24755884
PLoS One. 2017 Jul 10;12(7):e0180181
pubmed: 28692661
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31652904
N Engl J Med. 2004 Mar 18;350(12):1200-10
pubmed: 15028824
Nature. 2017 Jun 22;546(7659):498-503
pubmed: 28607485
Nat Med. 2020 Jun;26(6):878-885
pubmed: 32451495
Anticancer Agents Med Chem. 2016;16(9):1117-24
pubmed: 27039918
Clin Cancer Res. 2019 Aug 1;25(15):4674-4681
pubmed: 31068372
Nature. 2019 Nov;575(7781):217-223
pubmed: 31666701
J Clin Oncol. 2019 May 1;37(13):1062-1069
pubmed: 30817250
Cancer Discov. 2016 Jan;6(1):36-44
pubmed: 26546295
Mol Clin Oncol. 2013 Jul;1(4):788-792
pubmed: 24649248
Ann Oncol. 2021 May;32(5):600-608
pubmed: 33539945
Int J Cancer. 2018 Oct 15;143(8):2053-2064
pubmed: 29756206
Cancers (Basel). 2018 Jan 29;10(2):
pubmed: 29382159
Biomedicines. 2020 Aug 11;8(8):
pubmed: 32796566
Curr Pharm Des. 2011;17(21):2221-38
pubmed: 21777178
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Abdom Radiol (NY). 2018 Feb;43(2):301-313
pubmed: 29198002
PLoS One. 2014 Aug 05;9(8):e104346
pubmed: 25093849
Drugs. 2019 Jul;79(11):1249-1253
pubmed: 31256368
Cancers (Basel). 2019 Dec 09;11(12):
pubmed: 31835379
J Clin Oncol. 2014 Aug 10;32(23):2423-9
pubmed: 24982456
JCO Precis Oncol. 2018;2018:
pubmed: 30637364
J Clin Oncol. 2018 Feb 1;36(4):359-366
pubmed: 29232172
Cancer Res. 2012 Aug 15;72(16):3997-4007
pubmed: 22850419
J Oncol Pract. 2016 Oct;12(10):915-923
pubmed: 27858562
Clin Cancer Res. 2013 Mar 1;19(5):1035-43
pubmed: 23460534
Gastroenterology. 2017 Jan;152(1):68-74.e2
pubmed: 27856273
J Clin Oncol. 2009 Nov 20;27(33):5513-8
pubmed: 19858379
Transl Gastroenterol Hepatol. 2019 Jun 27;4:50
pubmed: 31304427
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
Acta Pharm Sin B. 2019 Sep;9(5):871-879
pubmed: 31649840
Ann Med. 2018 Jun;50(4):277-287
pubmed: 29537309
Curr Opin Gastroenterol. 2017 Sep;33(5):404-410
pubmed: 28682795
Immune Netw. 2018 Jun 25;18(3):e23
pubmed: 29984041
Cancer Immunol Immunother. 2013 May;62(5):949-54
pubmed: 23589109
Nature. 2020 Jan;577(7791):561-565
pubmed: 31942071
Curr Med Chem. 2017;24(13):1321-1331
pubmed: 28176634
Ann Gastroenterol Surg. 2019 Apr 25;3(4):368-372
pubmed: 31346575
World J Gastroenterol. 2014 Jun 28;20(24):7830-48
pubmed: 24976721
Cancer Res. 2015 Apr 15;75(8):1675-81
pubmed: 25878147
Eur J Cancer. 2014 Aug;50(12):2072-81
pubmed: 24915778
Cancer. 2007 Aug 1;110(3):525-33
pubmed: 17577216
Anticancer Agents Med Chem. 2013 Feb;13(2):276-80
pubmed: 22721387
World J Surg Oncol. 2017 Oct 10;15(1):183
pubmed: 29017581
Br J Surg. 2019 Nov;106(12):1590-1601
pubmed: 31454073
Lancet Gastroenterol Hepatol. 2016 Dec;1(4):298-306
pubmed: 28404200
J Immunother. 2010 Oct;33(8):828-33
pubmed: 20842054
J Surg Oncol. 2017 Jul;116(1):63-74
pubmed: 28346697
Chirurg. 2020 May;91(5):391-395
pubmed: 31965198
Lancet Oncol. 2016 Jun;17(6):801-810
pubmed: 27160474
J Control Release. 2020 May 10;321:23-35
pubmed: 32035193
J Clin Oncol. 2014 Feb 20;32(6):504-12
pubmed: 24419109
World J Gastroenterol. 2018 Nov 21;24(43):4846-4861
pubmed: 30487695
Cancer Discov. 2017 Sep;7(9):963-972
pubmed: 28578312
Transl Oncogenomics. 2016 Feb 21;7(Suppl 1):33-49
pubmed: 26917948
J Clin Oncol. 1997 Jun;15(6):2403-13
pubmed: 9196156
Ann Oncol. 2012 Nov;23(11):2799-2805
pubmed: 22771827
Cancer Treat Rev. 2017 Nov;60:32-43
pubmed: 28869888
Br J Cancer. 2014 Sep 9;111(6):1132-8
pubmed: 25072261
Cancer Discov. 2018 Sep;8(9):1087-1095
pubmed: 29802158
J Clin Oncol. 2019 Aug 10;37(23):2082-2088
pubmed: 31180816
Gut. 2013 Jan;62(1):112-20
pubmed: 22466618
Cell. 2015 Sep 24;163(1):160-73
pubmed: 26406376
N Engl J Med. 2017 Dec 28;377(26):2531-2544
pubmed: 29226797
Mol Cancer Ther. 2017 Nov;16(11):2598-2608
pubmed: 28835386
Hepatobiliary Surg Nutr. 2017 Jun;6(3):144-153
pubmed: 28652997
Lancet Oncol. 2017 Jun;18(6):770-778
pubmed: 28495639
Cancer Immunol Res. 2014 Feb;2(2):112-20
pubmed: 24579088
J Clin Oncol. 2017 Oct 20;35(30):3382-3390
pubmed: 28767289
World J Gastrointest Oncol. 2020 Feb 15;12(2):182-194
pubmed: 32104549
Hepatobiliary Surg Nutr. 2018 Oct;7(5):403-405
pubmed: 30498719
Br J Surg. 2019 Jul;106(8):1055-1065
pubmed: 30883699
Ann Surg Oncol. 2009 Jul;16(7):1725-6
pubmed: 19396495
Cancer Chemother Pharmacol. 2015 Sep;76(3):489-498
pubmed: 26126726